Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.
EN | CN

You are here:Home-Chemical Inhibitors & Agonists-Tyrosine Kinase-EGFR-BIBX 1382
BIBX 1382

Chemical Structure : BIBX 1382

CAS No.: 196612-93-8

BIBX 1382 (Falnidamol;BIBX-1382;BIBX1382)

Catalog No.: PC-42522Not For Human Use, Lab Use Only.

BIBX 1382 (Falnidamol) is a selective EGFR inhibitor with IC50 of 3 nM.

Packing Price Stock Quantity
5 mg $88 In stock
10 mg $128 In stock
25 mg $218 In stock
50 mg $358 In stock
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

BIBX 1382 (Falnidamol) is a selective EGFR inhibitor with IC50 of 3 nM.
BIBX 1382 shows weak activity against HER2 (IC50=3.4 uM) and no inhibition on IGF1R, HGFR, Src, and VEGFR2 (IC50>10 uM).
BIBX 1382 inhibits EGF-induced phosphorylation of EGFR in a dose-dependent manner in A431 cells; orally active in xenografts mice.

Physicochemical Properties

M.Wt 387.8418
Formula C18H19ClFN7
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

DMSO: ≥ 41 mg/mL

Chemical Name/SMILES

Pyrimido[5,4-d]pyrimidine-2,8-diamine, N8-(3-chloro-4-fluorophenyl)-N2-(1-methyl-4-piperidinyl)-

References

1. Solca FF, et al. J Pharmacol Exp Ther. 2004 Nov;311(2):502-9.

2. Hutzler JM, et al. Drug Metab Dispos. 2014 Oct;42(10):1751-60.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: